ABSTRACTAchlorophyllous unicellular microalgae of the genusPrototheca(Trebouxiophyceae,Chlorophyta) are the only known plants that cause infections in both humans and animals, collectively referred to as protothecosis. Human protothecosis, most commonly manifested as cutaneous, articular, and disseminated disease, is primarily caused byProtothecawickerhamii, followed byProtothecazopfiiand, sporadically, byProtothecacutisandProtothecamiyajii. In veterinary medicine, however,P. zopfiiis a major pathogen responsible for bovine mastitis, which is a predominant form of protothecal disease in animals. Historically, identification ofProtothecaspp. has relied upon phenotypic criteria; these were later replaced by molecular typing schemes, including DNA sequencing. However, the molecular markers interrogated so far, mostly located in the ribosomal DNA (rDNA) cluster, do not provide sufficient discriminatory power to distinguish among allProtothecaspp. currently recognized. Our study is the first attempt to develop a fast, reliable, and specific molecular method allowing identification of allProtothecaspp. We propose the mitochondrialcytbgene as a new and robust marker for diagnostics and phylogenetic studies of theProtothecaalgae. Thecytbgene displayed important advantages over the rDNA markers. Not only did thecytbgene have the highest discriminatory capacity for resolving allProtothecaspecies, but it also performed best in terms of technical feasibility, understood as ease of amplification, sequencing, and multiple alignment analysis. Based on the species-specific polymorphisms in the partialcytbgene, we developed a fast and straightforward PCR-restriction fragment length polymorphism (RFLP) assay for identification and differentiation of allProtothecaspecies described so far. The newly proposed method is advocated to be a new gold standard in diagnostics of protothecal infections in human and animal populations.